Tissue Bulking Agents, Urologic

Definition : Implantable liquid substances intended to be injected into urinary structure/tissues such as the urethra or ureters (e.g., the ureter wall close to the ureterovesical junction, periurethral tissue). These substances typically consist of an organic material (e.g., autologous chondrocytes) or more frequently of a biocompatible copolymer (e.g., dextranomer-hyaluronic acid) and a liquid solvent. The agent is frequently delivered using a needle attached to a catheter that is introduced through an endoscope. Urological tissue bulking agents are available for the treatment of specific disorders (e.g., vesicoureteral reflux, incontinence).

Entry Terms : "Tissue Bulking Agents, Incontinence" , "Tissue Bulking Agents, Vesicoureteral Reflux" , "Vesicoureteral Tissue Bulking Implants" , "Gastrourology Bulking Agents, Injectable" , "Bulking Agents, Injectable, Gastrourology"

UMDC code : 20727

U.S.companies only
Suppress Subsidiary Companies

1-3 of 3 Match(es).

Boston Scientific Corp

Company Type: Parent

In 1969, fascinated by the possibility of bringing pioneering medical devices and treatments to patients across the world, John Abele joined Medi-Tech, a company that was developing alternatives to traditional surgery. Pete Nicholas was looking for an investment, and when he met John, the pieces came together.

Carbon Medical Technologies Inc

Company Type: Parent

Carbon Medical Technologies, Inc. (CMT) develops, manufactures and markets proprietary carbon-coated implantable medical devices.

Cogentix Medical Inc (CGNT)

Company Type: Parent

1-3 of 3 Match(es).


Sign Up for Free e-newsletters

Medical Product Guide OBG Management Product Zone